Inbios Reagents

SOL #: 96463Special NoticeSole Source

Overview

Buyer

Health And Human Services
Centers For Disease Control And Prevention
CDC OFFICE OF ACQUISITION SERVICES
ATLANTA, GA, 30333, United States

Place of Performance

GA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Action Date
Mar 17, 2026, 9:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price purchase order to InBios International, Inc. for the InBios DENV Detect TM IgM Capture Elisa Kit. This special notice is for an FDA-approved serology test critical for the ongoing DENV surveillance program. Responses from interested parties will be considered to determine if a competitive procurement is feasible. Responses are due by March 27, 2026, 5 PM EST.

Scope of Work

The requirement is for the InBios DENV Detect TM IgM Capture Elisa Kit, which is the only serology test approved by the FDA for dengue diagnosis. This kit is essential for the Dengue Branch Diagnostic Laboratory's ongoing DENV surveillance program.

Contract & Timeline

  • Type: Intent to award a Sole Source Firm Fixed Price Purchase Order
  • Set-Aside: None (Sole Source Intent)
  • Response Due: March 27, 2026, 5 PM EST
  • Published: March 12, 2026
  • Department/Agency: Health And Human Services / CENTERS FOR DISEASE CONTROL AND PREVENTION
  • Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)

Evaluation

This notice is an intent to award sole source, not a request for competitive quotations. However, all quotations/responses received within 15 days of the notice's issuance will be considered by the government. The determination to not compete this proposed contract, based on responses, is solely at the government's discretion. Information received will primarily be used to assess the possibility of a competitive procurement.

Additional Notes

Interested parties should email their quotation/response to the contract specialist, Iris Gonzalez, at qsx8@cdc.gov by the specified deadline.

People

Points of Contact

Iris GonzalezPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Mar 12, 2026
Inbios Reagents | GovScope